HPGC Renmintongtai Pharmaceutical Corporation 600829.SS Stock
HPGC Renmintongtai Pharmaceutical Corporation Price Chart
HPGC Renmintongtai Pharmaceutical Corporation 600829.SS Financial and Trading Overview
Contents
- HPGC Renmintongtai Pharmaceutical Corporation Price Chart
- HPGC Renmintongtai Pharmaceutical Corporation 600829.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of HPGC Renmintongtai Pharmaceutical Corporation
- Q&A For HPGC Renmintongtai Pharmaceutical Corporation Stock
| HPGC Renmintongtai Pharmaceutical Corporation stock price | 6.41 CNY |
| Previous Close | 6.88 CNY |
| Open | 6.86 CNY |
| Bid | 6.86 CNY x 0 |
| Ask | 6.87 CNY x 0 |
| Day's Range | 6.83 - 6.94 CNY |
| 52 Week Range | 5.52 - 8.34 CNY |
| Volume | 2.69M CNY |
| Avg. Volume | 5.94M CNY |
| Market Cap | 3.98B CNY |
| Beta (5Y Monthly) | 0.587328 |
| PE Ratio (TTM) | 13.470589 |
| EPS (TTM) | 0.52 CNY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 27, 2021 |
| 1y Target Est | N/A |
600829.SS Valuation Measures
| Enterprise Value | 4.17B CNY |
| Trailing P/E | 13.470589 |
| Forward P/E | 11.45 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.39974988 |
| Price/Book (mrq) | 1.5713631 |
| Enterprise Value/Revenue | 0.418 |
| Enterprise Value/EBITDA | 9.607 |
Trading Information
HPGC Renmintongtai Pharmaceutical Corporation Stock Price History
| Beta (5Y Monthly) | 0.587328 |
| 52-Week Change | 16.61% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.34 CNY |
| 52 Week Low | 5.52 CNY |
| 50-Day Moving Average | 6.9 CNY |
| 200-Day Moving Average | 6.69 CNY |
600829.SS Share Statistics
| Avg. Volume (3 month) | 5.94M CNY |
| Avg. Daily Volume (10-Days) | 5.59M CNY |
| Shares Outstanding | 579.89M |
| Float | 120.09M |
| Short Ratio | N/A |
| % Held by Insiders | 76.58% |
| % Held by Institutions | 0.53% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 15:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 2.90% |
| Operating Margin (ttm) | 4.15% |
| Gross Margin | 9.50% |
| EBITDA Margin | 4.35% |
Management Effectiveness
| Return on Assets (ttm) | 3.73% |
| Return on Equity (ttm) | 12.11% |
Income Statement
| Revenue (ttm) | 9.97B CNY |
| Revenue Per Share (ttm) | 17.19 CNY |
| Quarterly Revenue Growth (yoy) | 13.90% |
| Gross Profit (ttm) | 917.54M CNY |
| EBITDA | 433.75M CNY |
| Net Income Avi to Common (ttm) | 289.1M CNY |
| Diluted EPS (ttm) | 0.51 |
| Quarterly Earnings Growth (yoy) | 55.60% |
Balance Sheet
| Total Cash (mrq) | 1.07B CNY |
| Total Cash Per Share (mrq) | 1.84 CNY |
| Total Debt (mrq) | 1.19B CNY |
| Total Debt/Equity (mrq) | 47.03 CNY |
| Current Ratio (mrq) | 1.498 |
| Book Value Per Share (mrq) | 4.372 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 307.47M CNY |
| Levered Free Cash Flow (ttm) | 274.65M CNY |
Profile of HPGC Renmintongtai Pharmaceutical Corporation
| Country | China |
| State | N/A |
| City | Harbin |
| Address | No. 418 Hayao Road |
| ZIP | 150071 |
| Phone | N/A |
| Website | https://www.hyrmtt.com.cn |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 3030 |
HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese medicines, Chinese herbal medicine, antibiotics, biological products, and biochemical drugs, as well as medical equipment and health products. It also provides logistics services, including warehousing and distribution; and hospital services comprising medical treatment, prevention, health care, rehabilitation, blood purification, and renal disease treatment. In addition, the company offers Chinese and Western medicines, Chinese herbal medicines, nourishing health care products, medical equipment, cosmetics, and daily necessities through an e-commerce platform. It operates chain stores in Heilongjiang Province. The company was founded in 1950 and is headquartered in Harbin, China. HPGC Renmintongtai Pharmaceutical Corporation is a subsidiary of Harbin Pharmaceutical Group Co., Ltd.
Q&A For HPGC Renmintongtai Pharmaceutical Corporation Stock
What is a current 600829.SS stock price?
HPGC Renmintongtai Pharmaceutical Corporation 600829.SS stock price today per share is 6.41 CNY.
How to purchase HPGC Renmintongtai Pharmaceutical Corporation stock?
You can buy 600829.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for HPGC Renmintongtai Pharmaceutical Corporation?
The stock symbol or ticker of HPGC Renmintongtai Pharmaceutical Corporation is 600829.SS.
Which industry does the HPGC Renmintongtai Pharmaceutical Corporation company belong to?
The HPGC Renmintongtai Pharmaceutical Corporation industry is Drug Manufacturers-Specialty & Generic.
How many shares does HPGC Renmintongtai Pharmaceutical Corporation have in circulation?
The max supply of HPGC Renmintongtai Pharmaceutical Corporation shares is 579.89M.
What is HPGC Renmintongtai Pharmaceutical Corporation Price to Earnings Ratio (PE Ratio)?
HPGC Renmintongtai Pharmaceutical Corporation PE Ratio is 12.32692300 now.
What was HPGC Renmintongtai Pharmaceutical Corporation earnings per share over the trailing 12 months (TTM)?
HPGC Renmintongtai Pharmaceutical Corporation EPS is 0.52 CNY over the trailing 12 months.
Which sector does the HPGC Renmintongtai Pharmaceutical Corporation company belong to?
The HPGC Renmintongtai Pharmaceutical Corporation sector is Healthcare.